US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist

3.2400
+0.0600+1.89%

Trading Nov 21 15:54 ET

28.19MMarket Cap-5586P/E (TTM)

Dare Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

25.71%-5.92M

295.93%12.9M

57.73%-6.81M

-114.81%-38.86M

-38.70%-8.18M

-192.72%-7.97M

22.04%-6.59M

-30.58%-16.12M

37.11%-18.09M

40.53%-5.9M

Net income from continuing operations

43.34%-4.7M

247.34%12.91M

16.00%-6.76M

2.54%-30.16M

68.28%-5.06M

-18.22%-8.3M

-2,216.49%-8.76M

4.24%-8.04M

20.02%-30.95M

-67.08%-15.94M

Operating gains losses

--22.44K

---22.44K

--600K

----

Depreciation and amortization

5.21%9.74K

60.55%15.44K

13.36%10.78K

58.51%38.36K

-6.04%9.98K

205.21%9.26K

80.77%9.62K

81.90%9.51K

-8.37%24.2K

50.73%10.62K

Other non cash items

48.97%139.7K

118.12%200.32K

125.34%202.67K

439.59%78.32K

-3,240.10%-197.23K

446.07%93.77K

366.21%91.84K

1,021.71%89.94K

55.52%-23.06K

77.95%-5.91K

Change In working capital

-363.22%-1.92M

-153.50%-762K

82.97%-1.5M

-206.01%-11.34M

-137.37%-3.55M

-102.74%-413.86K

115.11%1.42M

-96.73%-8.8M

22.59%10.7M

1,380.43%9.51M

-Change in receivables

168.78%383.29K

-73.52%483.5K

37.25%-436.46K

235.15%753.95K

-69.34%180.55K

-105.66%-557.29K

117.55%1.83M

-18.99%-695.55K

18.58%-557.84K

159.54%588.88K

-Change in prepaid assets

-63.07%-422.92K

259.83%1.58M

509.46%1.71M

85.55%-605.26K

383.65%1.06M

73.57%-259.35K

-214.44%-991.11K

90.30%-416.46K

-573.17%-4.19M

455.54%219.51K

-Change in payables and accrued expense

38.87%-563.51K

-180.40%-2.06M

88.66%-538.3K

-190.00%-6.91M

-171.69%-3.81M

-706.77%-921.85K

134.16%2.56M

-520.24%-4.75M

641.66%7.68M

519.53%5.31M

-Change in other current assets

99.01%-5.37K

343.44%243.16K

43.70%-207.14K

-382.19%-10.3K

1,238.58%845.84K

-796.76%-543.05K

--54.84K

---367.93K

-82.51%3.65K

-104.24%-74.29K

-Change in other current liabilities

-20.54%-121.22K

-19.86%-117.15K

-26.04%-120.8K

----

---100.57K

---97.74K

---95.85K

----

-Change in other working capital

-160.32%-1.19M

53.39%-898.21K

23.25%-1.9M

-158.84%-4.57M

-161.44%-2.13M

-67.16%1.97M

-97.41%-1.93M

-242.28%-2.48M

-13.56%7.76M

665.04%3.47M

Cash from discontinued investing activities

Operating cash flow

25.71%-5.92M

295.93%12.9M

57.73%-6.81M

-114.81%-38.86M

-38.70%-8.18M

-192.72%-7.97M

22.04%-6.59M

-30.58%-16.12M

37.11%-18.09M

40.53%-5.9M

Investing cash flow

Cash flow from continuing investing activities

1,377.55%282.33K

-285.23K

-7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

-334.24%-63.07K

-2.7K

Net PPE purchase and sale

1,377.55%282.33K

---285.23K

---7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

--0

-334.24%-63.07K

---2.7K

Cash from discontinued investing activities

Investing cash flow

1,377.55%282.33K

---285.23K

---7.3K

-898.00%-629.43K

-22,418.76%-607.33K

59.82%-22.1K

--0

-334.24%-63.07K

---2.7K

Financing cash flow

Cash flow from continuing financing activities

-94.91%436.44K

-74.49%115.37K

-98.92%14.03K

1,064.04%15.64M

530,926,900.00%5.31M

192,365.93%8.58M

-66.23%452.2K

1.3M

-98.23%1.34M

-100.00%-1

Net issuance payments of debt

-6.57%436.85K

---66.8K

---200.39K

--267.19K

---200.39K

--467.58K

--0

Net common stock issuance

--0

-59.54%182.98K

--215.11K

666.91%9.35M

--785.76K

--8.11M

--452.2K

--0

-98.38%1.22M

--0

Proceeds from stock option exercised by employees

--0

942.80%1.3M

200.00%1

--0

--1.3M

-76.61%124.6K

-100.00%-1

Net other financing activities

---405

---815

---690

--4.72M

----

Cash from discontinued financing activities

Financing cash flow

-94.91%436.44K

-74.49%115.37K

-98.92%14.03K

1,064.04%15.64M

530,926,900.00%5.31M

192,365.93%8.58M

-66.23%452.2K

--1.3M

-98.23%1.34M

-100.00%-1

Net cash flow

Beginning cash position

22.33%16.71M

-80.00%3.97M

-68.82%10.81M

-32.91%34.67M

-64.77%14.23M

-57.39%13.66M

-49.57%19.83M

-32.91%34.67M

1,006.64%51.67M

-11.37%40.39M

Current changes in cash

-996.92%-5.21M

307.61%12.73M

54.07%-6.81M

-41.89%-23.85M

41.06%-3.48M

-93.21%580.35K

13.73%-6.13M

-20.00%-14.82M

-135.71%-16.81M

-196.90%-5.9M

Effect of exchange rate changes

252.60%22.93K

146.75%14.56K

-78.26%-39.23K

95.12%-9.59K

-67.34%58.6K

93.49%-15.03K

77.07%-31.15K

-140.49%-22.01K

-208.78%-196.34K

1,063.84%179.43K

End cash Position

-18.95%11.53M

22.33%16.71M

-80.00%3.97M

-68.82%10.81M

-64.77%14.23M

-57.39%13.66M

-49.57%19.83M

-32.91%34.67M

Free cash flow

29.44%-5.64M

291.60%12.62M

57.68%-6.82M

-117.54%-39.49M

-48.94%-8.79M

-193.57%-8M

22.05%-6.59M

-30.53%-16.12M

36.93%-18.15M

40.51%-5.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	25.71%-5.92M	295.93%12.9M	57.73%-6.81M	-114.81%-38.86M	-38.70%-8.18M	-192.72%-7.97M	22.04%-6.59M	-30.58%-16.12M	37.11%-18.09M	40.53%-5.9M
Net income from continuing operations	43.34%-4.7M	247.34%12.91M	16.00%-6.76M	2.54%-30.16M	68.28%-5.06M	-18.22%-8.3M	-2,216.49%-8.76M	4.24%-8.04M	20.02%-30.95M	-67.08%-15.94M
Operating gains losses	--22.44K	---22.44K	--600K	----	----	----	----	----	----	----
Depreciation and amortization	5.21%9.74K	60.55%15.44K	13.36%10.78K	58.51%38.36K	-6.04%9.98K	205.21%9.26K	80.77%9.62K	81.90%9.51K	-8.37%24.2K	50.73%10.62K
Other non cash items	48.97%139.7K	118.12%200.32K	125.34%202.67K	439.59%78.32K	-3,240.10%-197.23K	446.07%93.77K	366.21%91.84K	1,021.71%89.94K	55.52%-23.06K	77.95%-5.91K
Change In working capital	-363.22%-1.92M	-153.50%-762K	82.97%-1.5M	-206.01%-11.34M	-137.37%-3.55M	-102.74%-413.86K	115.11%1.42M	-96.73%-8.8M	22.59%10.7M	1,380.43%9.51M
-Change in receivables	168.78%383.29K	-73.52%483.5K	37.25%-436.46K	235.15%753.95K	-69.34%180.55K	-105.66%-557.29K	117.55%1.83M	-18.99%-695.55K	18.58%-557.84K	159.54%588.88K
-Change in prepaid assets	-63.07%-422.92K	259.83%1.58M	509.46%1.71M	85.55%-605.26K	383.65%1.06M	73.57%-259.35K	-214.44%-991.11K	90.30%-416.46K	-573.17%-4.19M	455.54%219.51K
-Change in payables and accrued expense	38.87%-563.51K	-180.40%-2.06M	88.66%-538.3K	-190.00%-6.91M	-171.69%-3.81M	-706.77%-921.85K	134.16%2.56M	-520.24%-4.75M	641.66%7.68M	519.53%5.31M
-Change in other current assets	99.01%-5.37K	343.44%243.16K	43.70%-207.14K	-382.19%-10.3K	1,238.58%845.84K	-796.76%-543.05K	--54.84K	---367.93K	-82.51%3.65K	-104.24%-74.29K
-Change in other current liabilities	-20.54%-121.22K	-19.86%-117.15K	-26.04%-120.8K	----	----	---100.57K	---97.74K	---95.85K	----	----
-Change in other working capital	-160.32%-1.19M	53.39%-898.21K	23.25%-1.9M	-158.84%-4.57M	-161.44%-2.13M	-67.16%1.97M	-97.41%-1.93M	-242.28%-2.48M	-13.56%7.76M	665.04%3.47M
Cash from discontinued investing activities
Operating cash flow	25.71%-5.92M	295.93%12.9M	57.73%-6.81M	-114.81%-38.86M	-38.70%-8.18M	-192.72%-7.97M	22.04%-6.59M	-30.58%-16.12M	37.11%-18.09M	40.53%-5.9M
Investing cash flow
Cash flow from continuing investing activities	1,377.55%282.33K	-285.23K	-7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	0	0	-334.24%-63.07K	-2.7K
Net PPE purchase and sale	1,377.55%282.33K	---285.23K	---7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	--0	--0	-334.24%-63.07K	---2.7K
Cash from discontinued investing activities
Investing cash flow	1,377.55%282.33K	---285.23K	---7.3K	-898.00%-629.43K	-22,418.76%-607.33K	59.82%-22.1K	--0	--0	-334.24%-63.07K	---2.7K
Financing cash flow
Cash flow from continuing financing activities	-94.91%436.44K	-74.49%115.37K	-98.92%14.03K	1,064.04%15.64M	530,926,900.00%5.31M	192,365.93%8.58M	-66.23%452.2K	1.3M	-98.23%1.34M	-100.00%-1
Net issuance payments of debt	-6.57%436.85K	---66.8K	---200.39K	--267.19K	---200.39K	--467.58K	--0	--0	--0	--0
Net common stock issuance	--0	-59.54%182.98K	--215.11K	666.91%9.35M	--785.76K	--8.11M	--452.2K	--0	-98.38%1.22M	--0
Proceeds from stock option exercised by employees	--0	--0	--0	942.80%1.3M	200.00%1	--0	--0	--1.3M	-76.61%124.6K	-100.00%-1
Net other financing activities	---405	---815	---690	--4.72M	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-94.91%436.44K	-74.49%115.37K	-98.92%14.03K	1,064.04%15.64M	530,926,900.00%5.31M	192,365.93%8.58M	-66.23%452.2K	--1.3M	-98.23%1.34M	-100.00%-1
Net cash flow
Beginning cash position	22.33%16.71M	-80.00%3.97M	-68.82%10.81M	-32.91%34.67M	-64.77%14.23M	-57.39%13.66M	-49.57%19.83M	-32.91%34.67M	1,006.64%51.67M	-11.37%40.39M
Current changes in cash	-996.92%-5.21M	307.61%12.73M	54.07%-6.81M	-41.89%-23.85M	41.06%-3.48M	-93.21%580.35K	13.73%-6.13M	-20.00%-14.82M	-135.71%-16.81M	-196.90%-5.9M
Effect of exchange rate changes	252.60%22.93K	146.75%14.56K	-78.26%-39.23K	95.12%-9.59K	-67.34%58.6K	93.49%-15.03K	77.07%-31.15K	-140.49%-22.01K	-208.78%-196.34K	1,063.84%179.43K
End cash Position	-18.95%11.53M	22.33%16.71M	-80.00%3.97M	-68.82%10.81M	-68.82%10.81M	-64.77%14.23M	-57.39%13.66M	-49.57%19.83M	-32.91%34.67M	-32.91%34.67M
Free cash flow	29.44%-5.64M	291.60%12.62M	57.68%-6.82M	-117.54%-39.49M	-48.94%-8.79M	-193.57%-8M	22.05%-6.59M	-30.53%-16.12M	36.93%-18.15M	40.51%-5.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data